Andain, Inc. Engages American Capital Ventures for Comprehensive Investor Relations Services
BEVERLY HILLS, California, October 4, 2012 /PRNewswire/ --
Andain Inc. (OTCBB: ANDN), a company engaged in the commercialization of novel technologies in the biotech & medical fields, announced today that they have engaged American Capital Ventures ("ACV"), a leading provider of comprehensive investor relations services to companies in the micro- and small-cap market.
Sam Elimelech , President & CEO of Andain, commented, "As we continue moving our key technologies closer to market and our company closer to revenue growth, we have found it increasingly necessary to ally ourselves with an investor relations firm that will be a key resource for our shareholders and our company. We are excited to be working with ACV in this effort. They will be affording us comprehensive investor relations support, access to their extensive investor network and advice on how to better communicate our opportunity to the investment community."
Howard Gostfrand , President of American Capital Ventures, commented, "We found Andain to be a company of great potential given their key technologies, market opportunity and roadmap to commercialization. We look forward to collaborating with Sam and his management team on initiatives designed to showcase their technologies, expand their shareholder base, boost their visibility and increase their valuation in the market for the benefit of both the company and its shareholders."
Andain, Inc. commercializes novel technologies in the biotech and medical fields, and expedites their time-to-market. The Company's flag technologies include miniature disposable insulin pump, stem cell therapy for muscular injuries, and drug delivery nano-particles via inhalation. For more information, please visit http://www.andaininc.com.
ABOUT AMERICAN CAPITAL VENTURES
Founded in 1999, ACV is a comprehensive investor relations, financial marketing, capital markets advisory, and consulting firm, driven by hard work, passion and a commitment to our clients. ACV provides micro- and small-cap companies with the advice and the tools to foster their success as a growing public company. Well versed in proven investor relations and financial marketing strategies within the micro- and small-cap market, ACV has a solid reputation as a firm for going beyond the traditional scope of investor relations services. ACV employs a comprehensive approach to meeting client needs and invokes a collaborative, "roll up sleeves" stance with all clients. ACV works alongside management to put sound strategies in place to allow these companies to grow successfully, and ultimately, succeed in unlocking their true value. For more information, please visit http://www.amcapventures.com.
Forward-looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the company's Form 10-K filing and other filings with the U S. Securities and Exchange Commission (available at http://www.sec.gov). The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.
American Capital Ventures
Howard Gostfrand , President
SOURCE Andain Inc
More by this Source
Andain Inc. Announces its Innovative Organ-targeted Drug Delivery Nano-particles
Apr 29, 2013, 09:30 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.